VYVANSE Side Effects

7005039-8 | Cognitive Disorder, Dysphemia, Feeling Abnormal, Impaired Driving Ability, Loss Of Consciousness, Monoplegia, Paraesthesia
on Sep 20, 2010 Male patient from UNITED STATES , 43 years of age, weighting 274.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: cognitive disorder, dysphemia, feeling abnormal, impaired driving ability, loss of consciousness, monoplegia, paraesthesia. Vyvanse dosage: 1x Daily In Am.

7001618-2 | Arthralgia
Patient was taking Vyvanse (View Usage). Patient had the following side effects: arthralgia on Sep 17, 2010 from UNITED STATES Additional patient health information: Male patient , child 11 years of age, weighting 72.00 lb, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 1 Morning.

6999067-6 | Skin Reaction
Adverse event was reported on Sep 08, 2010 by a Male patient taking Vyvanse (View Usage) (Dosage: ) . Location: CANADA , 25 years of age, After Vyvanse was administered, patient had the following side effects: skin reaction.

6992270-0 | Convulsion
on Sep 14, 2010 Male patient from UNITED STATES , weighting 140.0 lb, was diagnosed with attention deficit/hyperactivity disorder, somnolence, sleep disorder (What is sleep disorder?), hypersomnia and was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Vyvanse dosage: 50 Mg, 1x/day:qd. During the same period patient was treated with LUNESTA (3 Mg, Unk) (View Lunesta Review and Lunesta Label ), PROVIGIL (200 Mg, Unk) (View Provigil Review and Provigil Label ).


6979898-9 | Abnormal Behaviour, Anger, Negativism
on Sep 01, 2010 Male patient from UNITED STATES , weighting 91.98 lb, was diagnosed with attention deficit/hyperactivity disorder, affective disorder, blood cholesterol increased, medical diet, insomnia and was treated with Vyvanse (View Usage). Patient had the following side effects: abnormal behaviour, anger, negativism. Vyvanse dosage: 30 Mg, 1x/day:qd. During the same period patient was treated with GUANFACINE HYDROCHLORIDE (1 Mg, 1x/day:qd) (View Guanfacine Hydrochloride Review and Guanfacine Hydrochloride Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), SEROQUEL (Unk, Unk) (View Seroquel Review and Seroquel Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ), MELATONIN (View Melatonin Review and Melatonin Label ). Patient was hospitalized.

6966717-X | Convulsion
Patient was taking Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: convulsion on Aug 30, 2010 from UNITED STATES Additional patient health information: Male patient , child 10 years of age, was diagnosed with convulsion and. Vyvanse dosage: 50 Mg, 1x/day:qd. During the same period patient was treated with TEGRETOL (Unk, Unk) (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

6964364-7 | Decreased Appetite, Hallucination, Paranoia
Adverse event was reported on Aug 27, 2010 by a Male patient taking Vyvanse (View Usage) (Dosage: 60 Mg, 1x/day:qd) was diagnosed with attention deficit/hyperactivity disorder, sleep disorder (What is sleep disorder?) and. Location: UNITED STATES , weighting 71.99 lb, Patient experienced the following unwanted or unexpected effects: decreased appetite, hallucination, paranoia. During the same period patient was treated with CLONIDINE (0.05mg Every Night) (View Clonidine Review and Clonidine Label ).

6962006-8 | Condition Aggravated, Depression, Suicidal Ideation
on Aug 27, 2010 Female patient from UNITED STATES , 58 years of age, weighting 250.0 lb, was diagnosed with attention deficit/hyperactivity disorder, depression (What is depression?), anxiety (What is anxiety?) and was treated with Vyvanse (View Usage). Patient had the following side effects: condition aggravated, depression (What is depression?), suicidal ideation. Vyvanse dosage: Unk, 1x/day:qd. During the same period patient was treated with PROZAC (40 Mg, 1x/day:qd) (View Prozac Review and Prozac Label ), XANAX (.25 Mg, As Req'd) (View Xanax Review and Xanax Label ).

6957461-3 | Convulsion
on Aug 26, 2010 Male patient from UNITED STATES , weighting 140.0 lb, was diagnosed with attention deficit/hyperactivity disorder, somnolence, sleep disorder (What is sleep disorder?), hypersomnia and was treated with Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: convulsion. Vyvanse dosage: 50 Mg, 1x/day:qd. During the same period patient was treated with LUNESTA (3 Mg, Unk) (View Lunesta Review and Lunesta Label ), PROVIGIL (200 Mg, Unk) (View Provigil Review and Provigil Label ).

6955565-2 | Tic
Patient was taking Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: tic (What is tic?) on Aug 26, 2010 from UNITED STATES Additional patient health information: Female patient , child 8 years of age, weighting 80.00 lb, . Vyvanse dosage: .

6944369-2 | Overdose
Adverse event was reported on Aug 23, 2010 by a Female patient taking Vyvanse (View Usage) (Dosage: 100mg Daily) . Location: UNITED STATES , child 8 years of age, Patient had the following side effects: overdose.

6937466-9 | Abdominal Pain Upper, Vomiting
on Aug 23, 2010 Male patient from UNITED STATES , child 7 years of age, weighting 43.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: abdominal pain upper, vomiting. Vyvanse dosage: 1 Capsule Once Daily In Am Po Just Today.

6928034-3 | Atrial Fibrillation
on Aug 16, 2010 Male patient from UNITED STATES , 13 years of age, weighting 190.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?). Vyvanse dosage: 1 Daily Po. Patient was hospitalized.

6927899-9 | Convulsion, Tic
Patient was taking Vyvanse (View Usage). Patient had the following side effects: convulsion, tic (What is tic?) on Aug 16, 2010 from UNITED STATES Additional patient health information: Male patient , child 8 years of age, weighting 58.00 lb, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 1 Capsule Daily Po.

6926219-3 | Chest Discomfort, Chest Pain, Dyspnoea
Adverse event was reported on Aug 13, 2010 by a Female patient taking Vyvanse (View Usage) (Dosage: 30mg Each Morning Po) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 25 years of age, weighting 200.0 lb, After Vyvanse was administered, patient had the following side effects: chest discomfort, chest pain (What is chest pain?), dyspnoea. Patient was hospitalized.

6859748-1 | Completed Suicide
on Jul 13, 2010 Male patient from UNITED STATES , child 9 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Vyvanse dosage: .

6859689-X | Aphagia
on Jul 19, 2010 Male patient from UNITED STATES , weighting 115.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient had the following side effects: aphagia. Vyvanse dosage: 50 Mg Daily.

6848050-X | Mountain Sickness Acute, Pulmonary Oedema
Patient was taking Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: mountain sickness acute, pulmonary oedema on Jul 01, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 184.0 lb, was diagnosed with attention deficit/hyperactivity disorder, prophylaxis and. Vyvanse dosage: 60 Mg, 1x/day:qd. During the same period patient was treated with DIAMOX /00016901/ (.5 Df, 2x/day:bid) (View Diamox /00016901/ Review and Diamox /00016901/ Label ). Patient was hospitalized.

6822171-X | Irritability, Somnolence, Tachycardia, Tremor
Adverse event was reported on Jul 07, 2010 by a Female patient taking Vyvanse (View Usage) (Dosage: 40 Mg Prn Po) was diagnosed with attention deficit/hyperactivity disorder, depression (What is depression?) and. Location: UNITED STATES , 20 years of age, Patient experienced the following unwanted or unexpected effects: irritability, somnolence, tachycardia, tremor. During the same period patient was treated with WELLBUTRIN XL (300 Mg Daily Po) (View Wellbutrin Xl Review and Wellbutrin Xl Label ), VITAMIN C (View Vitamin C Review and Vitamin C Label ), COENZYME Q10 (View Coenzyme Q10 Review and Coenzyme Q10 Label ), LORATADINE (View Loratadine Review and Loratadine Label ), AMBIEN (View Ambien Review and Ambien Label ), NUVARING (View Nuvaring Review and Nuvaring Label ).

6765179-5 | Hypophagia, Weight Decreased
on Jun 10, 2010 Female patient from UNITED STATES , weighting 43.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient had the following side effects: hypophagia, weight decreased. Vyvanse dosage: One Daily Po.

6760877-1 | No Therapeutic Response, Pain In Jaw
on Jun 07, 2010 Female patient from UNITED STATES , weighting 144.0 lb, was treated with Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: no therapeutic response, pain in jaw. Vyvanse dosage: 1 Once Daily Po.

6750169-9 | Aggression, Agitation, Dermatillomania, Hallucination, Visual, Insomnia
Patient was taking Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, agitation, dermatillomania, hallucination, visual, insomnia on May 27, 2010 from UNITED STATES Additional patient health information: Male patient , child 6 years of age, weighting 48.50 lb, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 20 Mg Once A Day Po. Patient was hospitalized.

6748479-4 | Abnormal Behaviour, Bruxism, Speech Disorder, Swollen Tongue, Tongue Biting, Tongue Disorder
Adverse event was reported on May 27, 2010 by a Male patient taking Vyvanse (View Usage) (Dosage: 20 Mg Qd Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , weighting 47.00 lb, Patient had the following side effects: abnormal behaviour, bruxism, speech disorder, swollen tongue, tongue biting, tongue disorder.

6739610-5 | Gait Disturbance
on May 12, 2010 Male patient from CANADA , child 6 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: gait disturbance. Vyvanse dosage: 20 Mg, 1x/day:qd.

6735165-X | Cardiac Arrest
on May 19, 2010 Male patient from UNITED STATES , 13 years of age, weighting 100.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?). Vyvanse dosage: 20mg Capsule One Per Day. Patient was hospitalized.

6730771-0 | Convulsion, Dependence, Hallucination, Heart Rate Increased, Overdose
Patient was taking Vyvanse (View Usage). Patient had the following side effects: convulsion, dependence, hallucination, heart rate increased, overdose on May 05, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 125.0 lb, was diagnosed with depression (What is depression?) and. Vyvanse dosage: . During the same period patient was treated with CORICIDIN (View Coricidin Review and Coricidin Label ), REMERON (View Remeron Review and Remeron Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), TRILEPTAL (View Trileptal Review and Trileptal Label ). Patient was hospitalized.

6724870-7 | Anger, Crying, Depression, Emotional Distress, Fear
Adverse event was reported on May 13, 2010 by a Male patient taking Vyvanse (View Usage) (Dosage: 40 Mg. 1/daily 3-5days/wk Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 19 years of age, weighting 140.2 lb, After Vyvanse was administered, patient had the following side effects: anger, crying, depression (What is depression?), emotional distress, fear.

6719528-4 | Aggression, Amnesia, Anger, Mania, Suicidal Ideation
on May 10, 2010 Female patient from UNITED STATES , 50 years of age, weighting 190.0 lb, was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, amnesia, anger, mania, suicidal ideation. Vyvanse dosage: . Patient was hospitalized.

6709231-9 | Blood Pressure Decreased, Dry Mouth, Somnolence
on Nov 30, 2009 Male patient from UNITED STATES , 52 years of age, weighting 160.1 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient had the following side effects: blood pressure decreased, dry mouth, somnolence. Vyvanse dosage: 70 Mg, 1x/day:qd, Oral. During the same period patient was treated with ALPRAZOLAN (ALPRAZOLAM) (View Alprazolan (alprazolam) Review and Alprazolan (alprazolam) Label ), LORTAB (View Lortab Review and Lortab Label ), PAXIL (View Paxil Review and Paxil Label ).

6709228-9 | Irritability, Negativism, Off Label Use, Psychomotor Hyperactivity
Patient was taking Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: irritability, negativism, off label use, psychomotor hyperactivity on Nov 30, 2009 from UNITED STATES Additional patient health information: Male patient , 13 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 1x/day:qd, Oral.

6709194-6 | Dry Mouth, Panic Attack
Adverse event was reported on Nov 25, 2009 by a Male patient taking Vyvanse (View Usage) (Dosage: 30 Mg, 1x/day:qd, Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 11 years of age, weighting 59.97 lb, Patient experienced the following unwanted or unexpected effects: dry mouth, panic attack.

6709190-9 | Impulsive Behaviour, Off Label Use
on Nov 24, 2009 Male patient from UNITED STATES , 15 years of age, weighting 149.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient had the following side effects: impulsive behaviour, off label use. Vyvanse dosage: 30 Mg, 1x/day:qd, Oral. During the same period patient was treated with MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ).

6709186-7 | Condition Aggravated, Frustration, Hypermetropia, Myopia
on Nov 23, 2009 Female patient from UNITED STATES , 52 years of age, weighting 119.9 lb, was treated with Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: condition aggravated, frustration, hypermetropia, myopia. Vyvanse dosage: 40 Mg, 1x/day:qd, Oral ; 70 Mg, 1x/day:qd, Oral. During the same period patient was treated with CELEXA (View Celexa Review and Celexa Label ), EFFEXOR (View Effexor Review and Effexor Label ).

6709185-5 | Headache, Hypersomnia, Off Label Use, Weight Decreased
Patient was taking Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), hypersomnia, off label use, weight decreased on Nov 23, 2009 from UNITED STATES Additional patient health information: Female patient , 14 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 40 Mg, 1x/day:qd, Oral.

6709184-3 | Anxiety, Crohn's Disease, Decreased Appetite, Migraine
Adverse event was reported on Nov 23, 2009 by a Female patient taking Vyvanse (View Usage) (Dosage: 30 Mg, 1x/day:qd, Oral : 60 Mg, 1x/day:qd, Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 42 years of age, weighting 149.9 lb, Patient had the following side effects: anxiety (What is anxiety?), crohn's disease (What is crohn's disease?), decreased appetite, migraine (What is migraine?). During the same period patient was treated with WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), PRISTIQ (DESVENLAFAXINE SUCCINATE) (View Pristiq (desvenlafaxine Succinate) Review and Pristiq (desvenlafaxine Succinate) Label ), ROWASA (View Rowasa Review and Rowasa Label ).

6707116-5 | Dizziness, Malaise, Nausea
on Dec 02, 2009 Male patient from UNITED STATES , 19 years of age, weighting 170.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: dizziness (What is dizziness?), malaise, nausea (What is nausea?). Vyvanse dosage: 70 Mg, 1x/day:qd, Oral.

6707070-6 | Hepatic Enzyme Increased, Off Label Use
on Dec 02, 2009 Male patient from UNITED STATES , 15 years of age, weighting 144.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased, off label use. Vyvanse dosage: 70 Mg, 1x/day:qd, Oral.

6707068-8 | Abnormal Sensation In Eye
Patient was taking Vyvanse (View Usage). Patient had the following side effects: abnormal sensation in eye on Dec 02, 2009 from UNITED STATES Additional patient health information: Female patient , child 9 years of age, weighting 61.95 lb, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 30 Mg, 1x/day:qd, Oral.

6707065-2 | Dermatitis
Adverse event was reported on Dec 23, 2009 by a Female patient taking Vyvanse (View Usage) (Dosage: 20 Mg, 1x/day:qd, Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 8 years of age, weighting 50.71 lb, After Vyvanse was administered, patient had the following side effects: dermatitis.

6707053-6 | Amenorrhoea
on Dec 01, 2009 Female patient from UNITED STATES , child 12 years of age, weighting 119.9 lb, was diagnosed with attention deficit/hyperactivity disorder, disturbance in attention and was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: amenorrhoea. Vyvanse dosage: 20 Mg, 1x/day:qd, Oral ; 30 Mg, 1x/day:qd, Oral ; 40 Mg, 1x/day:qd, Oral.

6707051-2 | Abdominal Discomfort, Decreased Appetite, Hypersensitivity, Irritability, Mood Swings, Overdose
on Jan 20, 2010 Male patient from UNITED STATES , child 10 years of age, weighting 112.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient had the following side effects: abdominal discomfort, decreased appetite, hypersensitivity, irritability, mood swings, overdose. Vyvanse dosage: See Image. During the same period patient was treated with TEGRETOL XR (View Tegretol-xr Review and Tegretol-xr Label ).

6707050-0 | Dyscalculia
Patient was taking Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: dyscalculia on Nov 30, 2009 from UNITED STATES Additional patient health information: Female patient , 50 years of age, weighting 142.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 50 Mg, One Dose, Oral : 50 Mg, 1x/day:qd, Oral. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), MULTIVITAMIN (ASCORBIC ACID, CALCIUM PANTOTHENATE, ERGOCALCIFEROL, NIC (View Multivitamin (ascorbic Acid, Calcium Pantothenate, Ergocalciferol, Nic Review and Multivitamin (ascorbic Acid, Calcium Pantothenate, Ergocalciferol, Nic Label ).

6707035-4 | Mood Swings, Overdose, Ventricular Extrasystoles
Adverse event was reported on Nov 30, 2009 by a Male patient taking Vyvanse (View Usage) (Dosage: 140 Mg (2 X 70mg Capsules), 1x/day:qd, Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 40 years of age, weighting 209.9 lb, Patient experienced the following unwanted or unexpected effects: mood swings, overdose, ventricular extrasystoles.

6707033-0 | Blood Bilirubin Increased
on Nov 30, 2009 Female patient from UNITED STATES , 19 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient had the following side effects: blood bilirubin increased. Vyvanse dosage: 50 Mg, 1x/day:qd, Oral. During the same period patient was treated with ZYRTEC (View Zyrtec Review and Zyrtec Label ).

6706663-X | Eye Pain, Off Label Use
on Dec 10, 2009 Female patient from UNITED STATES , 49 years of age, weighting 112.0 lb, was diagnosed with depression (What is depression?) and was treated with Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: eye pain, off label use. Vyvanse dosage: 50 Mg, 1x/day:qd, Oral; 70 Mg, 1x/day:qd, Oral. During the same period patient was treated with CELEXA (View Celexa Review and Celexa Label ).

6706658-6 | Musculoskeletal Chest Pain, Off Label Use
Patient was taking Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: musculoskeletal chest pain, off label use on Dec 09, 2009 from UNITED STATES Additional patient health information: Male patient , 14 years of age, . Vyvanse dosage: 50 Mg, 1x/day:qd, Oral.

6706657-4 | Decreased Appetite, Emotional Distress, Flat Affect, Insomnia
Adverse event was reported on Dec 08, 2009 by a Male patient taking Vyvanse (View Usage) (Dosage: 20 Mg, 1x/day:qd, Oral; 20 Mg, 1x/day:qd, Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 11 years of age, weighting 85.98 lb, Patient had the following side effects: decreased appetite, emotional distress, flat affect, insomnia.

6706632-X | Testicular Pain
on Dec 07, 2009 Male patient from UNITED STATES , 41 years of age, weighting 172.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: testicular pain. Vyvanse dosage: 50 Mg, 1x/day:qd, Oral. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ).

6706628-8 | Enuresis, Faecal Incontinence
on Dec 08, 2009 Male patient from UNITED STATES , child 7 years of age, was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: enuresis, faecal incontinence. Vyvanse dosage: 1x/day:qd, Oral.

6706610-0 | Oropharyngeal Pain, Pharyngeal Erythema, Rash, Urticaria
Patient was taking Vyvanse (View Usage). Patient had the following side effects: oropharyngeal pain, pharyngeal erythema, rash (What is rash?), urticaria on Dec 04, 2009 from UNITED STATES Additional patient health information: Male patient , 33 years of age, weighting 185.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 20 Mg, 1x/day:qd, Oral. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), STRATTERA (View Strattera Review and Strattera Label ).